Company profile for Saol therapeutics

Saol Therapeutics

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

12 News #PharmaBuzz

media
12 News #PharmaBuzz

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

An estimated 350 million people worldwide struggle with rare diseases, but only about 5% of those diseases have therapies available for their treatment. The development of these treatments –sometimes called “orphan drugs” –face special challenges. Due to the infrequency of patients presenting with these conditions, there is often a lack of understanding and experience within the medical community about managing and tre...

An estimated 350 million people worldwide struggle with rare diseases, but only about 5% of those diseases have therapies available for their treatment. The development of these treatments –sometimes called “orphan drugs” –face special challenges. Due to the infrequency of patients presenting with these conditions, there is often a lack of understanding and experience within the medical community about managing and treating them. Additionally, drug development costs may lead to funding challenges in the efforts to bring effective therapies to these small patient populations.

DCAT WeekDCAT Week

Not Confirmed

Not Confirmed

23-26 March, 2026

New York, U.S.A
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California
Biotech ShowcaseBiotech Showcase

Not Confirmed

Not Confirmed

12-14 January, 2026

San Diego, California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

1000 Holcomb Woods Parkway Suite 270 Roswell, GA 30076

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://saolrx.com/contact-us/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Saol Therapeutics Secures FDA Type A Meeting For SL1009

09 Dec 2025

// PR NEWSWIRE

FDA Issues Complete Response Letter to Saol for SL1009 (DCA)

08 Sep 2025

// PR NEWSWIRE

Saol Therapeutics Poster at UMDF Mitochondrial Med. Conf. 2025

19 Jun 2025

// PR NEWSWIRE

Saol Announces Clinical Milestones in Development Program

17 Apr 2025

// PR NEWSWIRE

Saol's SL1009 NDA Accepted for Pyruvate Dehydrogenase Deficiency

28 Jan 2025

// PR NEWSWIRE

Saol Therapeutics Submits NDA to FDA for SL1009

03 Dec 2024

// PR NEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search